Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France

Please find below news from France as well as about organisations from this country.

Total search results: 1859 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt. 2018-12-10
Abivax S.A.. (12/6/18). "Press Release: Abivax Receives DSMB Recommendation to Continue Ongoing Extension Study of Its Completed Phase 2a Clinical Trial in Ulcerative Colitis patients". Paris. 2018-12-06
Valneva S.E.. (12/6/18). "Press Release: Valneva and Hookipa Sign a Collaboration and Manufacturing Agreement". Saint-Herblain & Vienna. 2018-12-06
L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. 2018-12-05
Domain Therapeutics S.A.. (12/4/18). "Press Release: Domain Therapeutics Signs a Multi-target Research Collaboration and License Agreement with Boehringer Ingelheim on G Protein-Coupled Receptors (GPCRs) for Central Nervous System Disorders". Strasbour 2018-12-04
Anagenesis Biotechnologies. (12/4/18). "Press Release: Anagenesis Biotechnologies Announces a €3 Million Investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est". Strasbourg. 2018-12-04
Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent". 2018-11-29
Carbios S.A.. (11/28/18). "Press Release: Carbios and Kem One Sign a Letter of Intent to Implement a PET Biorecycling Demonstration Plant Operated by Carbios in the French Chemical Valley". Clermont-Ferrand. 2018-11-28
Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. 2018-11-22
Stilla Technologies S.A.S.. (11/20/18). "Press Release: Stilla Technologies Completes €16 Million ($18 Million) Series A". Paris. 2018-11-20
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. 2018-11-15
Ipsen S.A.. (11/15/18). "Press Release: European Commission Approves Ipsen’s Cabometyx (cabozantinib) for the Treatment of Hepatocellular Carcinoma in Adults Previously Treated with Sorafenib". Paris. 2018-11-15
IntegraGen S.A.. (11/12/18). "Press Release: IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers". Paris. 2018-11-12
Quantum Genomics S.A.. (11/12/18). "Press Release: Quantum Genomics Announces Excellent Topline Results from Phase 2b NEW-HOPE Study Evaluating Firibastat for Arterial Hypertension". Paris & New York, NY. 2018-11-12
bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile. 2018-11-09
Edinburgh Molecular Imaging Ltd.. (11/8/18). "Press Release: Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer". Edinburgh. 2018-11-08
Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies. 2018-11-07
Allogene Therapeutics, Inc.. (11/1/18). "Press Release: Allogene Therapeutics Announces Data Presentations Supporting Its Allogeneic CAR T Pipeline Program at 60th American Society of Hematology (ASH) Annual Meeting". South San Francisco, CA. 2018-11-01
Sanofi S.A.. (11/1/18). "Press Release: Sanofi and Denali Therapeutics to Develop Treatments for Neurological and Inflammatory Diseases". Paris. 2018-11-01
Denali Therapeutics Inc.. (11/1/18). "Press Release: Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases". South San Francisco, CA. 2018-11-01
PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification". 2018-10-31
Sanofi S.A.. (10/31/18). "Press Release: Sanofi Q3 2018 Performance Confirms Return to Growth". Paris. 2018-10-31
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
Microbiotica Ltd.. (10/24/18). "Press Release: Microbiotica Attracts Equity Investment from Seventure’s Health for Life Capital Fund". Cambridge. 2018-10-24
Innate Pharma S.A.. (10/23/18). "Press Release: Innate Pharma Strengthens and Expands Its Oncology Development Collaboration with AstraZeneca". Marseille. 2018-10-23
Hybrigenics S.A.. (10/23/18). "Press Release: Clinical Study of Inecalcitol in Acute Myeloid Leukemia Stopped for Futility. The Clinical Development of Inecalcitol Is Discontinued". Paris. 2018-10-23
Enterome S.A.. (10/23/18). "Press Release: Enterome Signs Global Licensing, Co-development and Co-Promotion Agreement with Takeda for the Treatment of Crohn’s Disease". Paris & Cambridge, MA. 2018-10-23
Acticor Biotech. (10/17/18). "Press Release: Acticor Biotech Raises €15.3M in a Series B Financing". Paris. 2018-10-17
Sanofi S.A.. (10/16/18). "Press Release: Dupixent (dupilumab) Showed Positive Topline Results in Two Phase 3 trials of Patients with Chronic Rhinosinusitis with Nasal Polyps". Paris & Tarrytown, NY. 2018-10-16
Boehringer Ingelheim. (10/12/18). "Press Release: Boehringer Ingelheim Inaugurates Its New Global Centre for Veterinary Vaccine R&D in Lyon, France". Lyon. 2018-10-12
Adocia S.A.. (10/11/18). "Press Release: Adocia Informs about a Civil Action Filed by Eli Lilly". Lyon. 2018-10-11
Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY. 2018-10-09
Euronext N.V.. (10/8/18). "Press Release: Medincell Lists on Euronext Paris. €30 Million Raised, Market Capitalisation €144 Million". Paris. 2018-10-08
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Novasep S.A.. (10/2/18). "Press Release: Novasep Opens €27m New Viral Vector Commercial Production Facility". Lyon. 2018-10-02
Sanofi S.A.. (10/1/18). "Press Release: Sanofi Completes Divestiture of Zentiva to Advent". Paris. 2018-10-01
Sanofi S.A.. (9/28/18). "Press Release: FDA Approves Libtayo (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma". Paris & Tarrytown, NY. 2018-09-28
Valneva S.E.. (9/27/18). "Press Release: Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-27
Valneva S.E.. (9/26/18). "Press Release: Valneva Launches a Capital Increase of Approximately €40 Million [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-26
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon. 2018-09-25
PathoQuest S.A.S.. (9/25/18). "Press Release: PathoQuest Names Dr. Christiane Honisch to Board of Directors". Paris. 2018-09-25
Thermo Fisher Scientific Inc.. (9/24/18). "Press Release: New Single Quadrupole Mass Spectrometry Technology Designed for Chromatographers Performing LC-MS Routine Analysis". Cannes-Mandelieu. 2018-09-24
Erytech Pharma. (9/20/18). "Press Release: Erytech Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer". Lyon & Cambridge, MA. 2018-09-20
Valneva S.E.. (9/20/18). "Press Release: Valneva Announces Extension of Drawdown Period for Its Existing European Investment Bank Loan". Saint-Herblain. 2018-09-20
Cellectis S.A.. (9/19/18). "Press Release: CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board". New York, NY. 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
Horama S.A.. (9/18/18). "Press Release: Horama Completes Its 22.5 Million Euros Series B Financing Round". Paris. 2018-09-18
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
Sanofi S.A.. (9/15/18). "Press Release: Positive Phase 3 Results Presented for Dupixent (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2018-09-15
Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris. 2018-09-13
Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA. 2018-09-11
Erytech Pharma. (9/10/18). "Press Release: Erytech Reports First Half of 2018 Financial Results and Provides Business Update". Lyon & Cambridge, MA. 2018-09-10
Allogene Therapeutics, Inc.. (9/6/18). "Press Release: Allogene Therapeutics Completes a $120 Million Private Financing". South San Francisco, CA. 2018-09-06
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Sanofi S.A.. (9/4/18). "Press Release: Sanofi Reaches Civil Settlement with US SEC". Paris. 2018-09-04
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
Adocia S.A.. (8/30/18). "Press Release: Adocia Announces Update to Second Arbitration Against Eli Lilly & Company". Lyon. 2018-08-30
CiToxLab S.A.. (8/30/18). "Press Release: CiToxLab Appoints Christophe Berthoux as CEO, Europe". Evreux. 2018-08-30
BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. 2018-08-30
British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". 2018-08-25
Novasep S.A.. (8/21/18). "Press Release: Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s". Lyon. 2018-08-21
Transgene S.A.. (8/20/18). "Press Release: Transgene Completes the Sale of the Greater China Rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 Million in Newly-Issued Shares". Strasbourg. 2018-08-20
Adocia S.A.. (8/20/18). "Press Release: American Arbitration Association Panel Finds In Favor Of Adocia In First Phase Of Arbitration Against Eli Lilly". Lyon. 2018-08-20
Genkyotex S.A.. (8/20/18). "Press Release: Genkyotex Secures an up to €7.5 Million Gross Financing to further Expand the Development of Its Lead Product". Archamps. 2018-08-20
Onxeo S.A.. (7/27/18). "Press Release: Onxeo Reports Half-Year 2018 Financial Results and Provides Business Outlook". Paris. 2018-07-27
Sanofi S.A.. (7/26/18). "Press Release: Sanofi Head of Human Resources Roberto Pucci to Retire, Company Names Caroline Luscombe to Take over October 1st". Paris. 2018-07-26
Nanobiotix S.A.. (7/26/18). "Press Release: Nanobiotix Signs a 40 M€ Non-dilutive Financing Agreement with the European Investment Bank". Paris & Cambridge, MA. 2018-07-26
Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris. 2018-07-25
Sangamo Therapeutics, Inc.. (7/23/18). "Press Release: Sangamo Therapeutics to Acquire TxCell". Richmond, CA & Valbonne. 2018-07-23
bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review". 2018-07-18
Revolution Medicines, Inc.. (7/18/18). "Press Release: Sanofi and Revolution Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers". Cambridge, MA & Redwood City, CA. 2018-07-18
Adocia S.A.. (7/18/18). "Press Release: Adocia Presents First Half 2018 Financial Results. Strategic Alliance Signed with Tonghua Dongbao, the Chinese Insulin Leader". Lyon. 2018-07-18
Thermo Fisher Scientific Inc.. (7/17/18). "Press Release: New Thermo Scientific B•R•A•H•M•S PCT Direct Blood Test Allows Fast Bacterial Infection and Sepsis Diagnosis at Patient's Point of Care". Hennigsdorf. 2018-07-17
HalioDx S.A.S.. (7/16/18). "Press Release: HalioDx Signs an Agreement with Sohin to Make Immunoscore Colon Assay Available in Mexico". Marseille. 2018-07-16
SenzaGen AB. (7/16/18). "Press Release: SenzaGen Signs Distribution Agreement with the French Test Laboratory Eurosafe". Lund. 2018-07-16
Thermo Fisher Scientific Inc.. (7/12/18). "Press Release: Thermo Scientific Krios Cryo-TEM Instrument Installed at the Institut Pasteur". Hillsboro, OR. 2018-07-12
Scienion AG. (7/12/18). "Press Release: Cellenion and Miltenyi Biotec Sign Co-Marketing Agreement to Provide a Time and Cost-Efficient Solution for the Development of Monoclonal Cell Lines". Berlin & Bergisch Gladbach. 2018-07-12
Antabio S.A.S.. (7/12/18). "Press Release: Antabio Completes € 12.5m Series A. New Investors Omnes, BNP Paribas Développement and Sham Innovation Santé Invest an Additional €5.2m". Labège. 2018-07-12
Dynacure S.A.S.. (7/10/18). "Press Release: Dynacure Names Chris Freitag (MD) Chief Medical Officer". Strasbourg. 2018-07-10
PathoQuest S.A.S.. (7/10/18). "Press Release: PathoQuest Announces New Appointments to Executive Leadership Team". 2018-07-10
Boehringer Ingelheim. (7/10/18). "Press Release: Boehringer Ingelheim Invests more than €200 Million to Establish Strategic Production Center for Veterinary Public Health in France". Ingelheim & Lyon. 2018-07-10
TxCell S.A.. (7/9/18). "Press Release: TxCell Exercises In-license Option to the University of British Columbia's Intellectual Property Rights of the HLA-A2 CAR-Treg Program". Valbonne. 2018-07-09
Yposkesi. (7/9/18). "Press Release: Yposkesi Appoints Dr. Fraser Wright as Senior Advisor". Corbeil-Essonnes. 2018-07-09
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top